REDESIGNER DRUGS Trademark

Trademark Overview


On Thursday, April 26, 2007, a trademark application was filed for REDESIGNER DRUGS with the United States Patent and Trademark Office. The USPTO has given the REDESIGNER DRUGS trademark a serial number of 77166972. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2010. This trademark is owned by Reviva Pharmaceuticals, Inc.. The REDESIGNER DRUGS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug research and development, including conducting clinical trials and consulting services related thereto; pharmaceutical research and development services, namely, designing, conducting and managing clinical trials and reporting the results of same; providing analysis and design services in the field of drug development and conducting clinical trials of newly developed drugs
redesigner drugs

General Information


Serial Number77166972
Word MarkREDESIGNER DRUGS
Filing DateThursday, April 26, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2008

Trademark Statements


Disclaimer with Predetermined Text"DRUGS"
Goods and ServicesPharmaceutical drug research and development, including conducting clinical trials and consulting services related thereto; pharmaceutical research and development services, namely, designing, conducting and managing clinical trials and reporting the results of same; providing analysis and design services in the field of drug development and conducting clinical trials of newly developed drugs

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 1, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReviva Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95138

Party NameReviva Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95138

Trademark Events


Event DateEvent Description
Monday, August 2, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 2, 2010ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 7, 2010EXTENSION 3 GRANTED
Friday, January 1, 2010EXTENSION 3 FILED
Monday, January 4, 2010TEAS EXTENSION RECEIVED
Wednesday, July 1, 2009EXTENSION 2 GRANTED
Monday, June 29, 2009EXTENSION 2 FILED
Monday, June 29, 2009TEAS EXTENSION RECEIVED
Wednesday, January 14, 2009EXTENSION 1 GRANTED
Tuesday, December 30, 2008EXTENSION 1 FILED
Wednesday, January 14, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 30, 2008TEAS EXTENSION RECEIVED
Tuesday, July 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2008NOTICE OF PUBLICATION
Thursday, March 6, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 3, 2008ASSIGNED TO LIE
Thursday, February 7, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2008EXAMINER'S AMENDMENT ENTERED
Thursday, February 7, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2008EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, August 9, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 9, 2007NON-FINAL ACTION E-MAILED
Thursday, August 9, 2007NON-FINAL ACTION WRITTEN
Thursday, August 9, 2007ASSIGNED TO EXAMINER
Tuesday, May 1, 2007NEW APPLICATION ENTERED IN TRAM